Author

Ant Murphy

Purdue University West LafayetteORCID 0009-0002-2467-4491Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Alejandra Romero AlzateiD· 1 shared Annaleigh BentoniD· 1 shared Bozhi LiuiD· 1 shared Jason A. HannaiD· 1 shared Lauren E. GartenhausiD· 1 shared Madison E. Yates· 1 shared Majid KazemianiD· 1 shared Nadia A. LanmaniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alejandra Romero AlzateORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Canonical microRNA loss drives tumor development implicating therapeutic efficacy of enoxacin in angiosarcoma

Ant Murphy, Bozhi Liu, Annaleigh Benton, Lauren E. Gartenhaus, Samuel Hartzler, Madison E. Yates, Alejandra Romero Alzate, Nimod D. Janson, Shyaman Jayasundara, Sagar M. Utturkar, Nadia A. Lanman, Majid Kazemian, Jason A. Hanna

The paper shows that loss of miRNA processing drives angiosarcoma and that enoxacin enhances miRNA expression, reducing tumor cell viability and migration.

bioRxiv · Jul 15, 2025 · PreprintCancer Biology